Relmada Therapeutics, Inc.
RLMD
Jodie situation report
Relmada Therapeutics, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 4 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.
- RLMD's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if RLMD's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind RLMD
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
AARDFiling-linked namecompetitorMar 19, 2026 ▾
“Our chief competitors include companies such as Johnson and Johnson, CG Oncology, UroGen, Soleno Therapeutics, Aardvark Therapeutics, and Protara Therapeutics, among others.”
CGONCG Oncology, Inc.competitorMar 19, 2026 ▾
“Our chief competitors include companies such as Johnson and Johnson, CG Oncology, UroGen, Soleno Therapeutics, Aardvark Therapeutics, and Protara Therapeutics, among others.”
Depended on by
URGNUroGen Pharma Ltd.competitorMar 2, 2026 ▾
“We are aware of several pharmaceutical companies that are developing drugs in the general fields of urology and uro-oncology, such as AstraZeneca, Aura Biosciences., Bristol Myers Squibb, CG Oncology, enGene Holdings, Ferring Pharmaceuticals, Fidia Pharmaceut…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
RLMD is currently a Leader in the organic co-movement group Biotech Clinical Trials. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for RLMD; it is not active in the latest market snapshot.